Information about H2 Equity Partners Management Fund III
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

H2 Equity Partners Management Fund III (SRL)

Company information

Status
Active

KVK number

34261736

VAT Number

Established
13-12-2006
Last balance sheet year
2024
Company size
Micro 0 FTE
RSIN number
817347501
Principal activity
Activiteiten van financieringsentiteiten binnen concernverband
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from H2 Equity Partners Management Fund III

2024 2023 2022 2021
Equity 16.364 -9 % 17.900 -4 % 18.686 -5 % 19.750
Employees 0 0 0 0

Frequently asked questions

What is the VAT number of H2 Equity Partners Management Fund III?
Log in or start a free trial to view the VAT number.
What is the KVK number of H2 Equity Partners Management Fund III?
The KVK number of H2 Equity Partners Management Fund III is 34261736
When was H2 Equity Partners Management Fund III founded?
H2 Equity Partners Management Fund III was founded on 13-12-2006.
What is the address of H2 Equity Partners Management Fund III?
The current registered office of H2 Equity Partners Management Fund III is located at Oosteinde 19, 1017 WT Amsterdam.
When was the last time H2 Equity Partners Management Fund III filed their annual financial statements?
The most recent financial statements of H2 Equity Partners Management Fund III were filed on 25-06-2025.
How many employees does H2 Equity Partners Management Fund III have?
There are currently no employees working at H2 Equity Partners Management Fund III or no workforce information is available.
What is the annual turnover of H2 Equity Partners Management Fund III?
There is no turnover available for H2 Equity Partners Management Fund III.